Sponsors: []Modifications:     26-40-101.This chapter is known as the "Genetic Testing Privacy Act."    26-40-102.As used in this chapter:(1)  "Compulsory disclosure" means any disclosure of genetic information mandated orrequired by federal or state law in connection with a judicial, legislative, or administrativeproceeding.(2)  "Disclose" or "disclosure" means to convey or to provide access to private geneticinformation to a person other than the individual.(3)  "DNA" means deoxyribonucleic acid.(4)  "DNA sample" means any human biological specimen from which DNA can beextracted, or DNA extracted from such specimen.(5)  "DNA typing" means a scientifically reliable method for characterizing and comparingsequences of DNA, and applying a statistical analysis of population frequency to determine thatif the DNA sequences match, the probability that the match occurs by chance.(6)  "Employer" is as defined in Section 34A-2-103.(7)  "Genetic test" means the analysis of an individually identifiable DNA sample.(8)  "Health insurer" means an insurer, as defined in Section 31A-1-301, who offersinsurance governed by Title 31A, Chapter 22, Part VI, Disability Insurance.(9)  "Identifiable individual" means any individual whose name, address, Social Securitynumber, health insurance identification number, or similar identifying information is known,available, or can be determined with reasonable accuracy either directly or by reference to otherinformation.(10)  "Individual" means:(a)  the person from whose body the DNA sample originated;(b)  a person who is authorized to make health care decisions concerning a minor or anincompetent person from whose body or DNA sample originated; or(c)  the administrator or executor of a deceased person's estate, if any, otherwise the nextof kin of a deceased person from whose body a DNA sample originated.(11)  "Individual identifier" means a name, address, Social Security number, healthinsurance identification number, or similar information by which the identity of an individual canbe determined with reasonable accuracy, either directly or by reference to other availableinformation.  The term does not include characters, number, or codes assigned to an individual ora DNA sample which cannot be used to determine the individual's identity.(12)  "Institutional Review Board" means a board established in accordance with 45 CFR46.102(g)(1992) as such regulation may be amended.(13)  "Life insurer" means an insurer, as defined in Section 31A-1-301, who offersinsurance governed by Title 31A, Chapter 22, Part IV, Life Insurance and Annuities.(14)  "Person" means all persons, organizations, and entities other than the individual.(15)  "Private genetic information" means any information about an identifiable individualthat is derived from the presence, absence, alteration, or mutation of a gene or genes, or thepresence or absence of a specific DNA marker or markers, and which has been obtained:(a)  from a test or analysis of the individual's DNA; or(b)  from a test or analysis of a person to whom the individual is related.(16)  "Research subject" means:(a)  a person whose DNA sample is analyzed as part of a research project;(b)  a person who is authorized to make health care decisions concerning a minor orincompetent person whose DNA sample is analyzed as part of a research project; or(c)  the administrator or executor of a deceased person's estate, if any, otherwise the nextof kin of a deceased person whose DNA sample is analyzed as part of a research project.    26-40-103.Except as provided in Section 26-40-110, no person may collect or cause to be collectedan individually identifiable DNA sample for genetic analysis without verbally informing theindividual:(1)  that consent to the collection and the taking of the DNA is voluntary;(2)  that consent to the genetic analysis is voluntary;(3)  of the information that can be reasonably expected to be derived from the geneticanalysis;(4)  of the use, if any, that the individual will be able to make of the information derivedfrom the genetic analysis;(5)  of the right to inspect records that contain information derived from the geneticanalysis;(6)  of the right to have the DNA sample destroyed;(7)  of the right to revoke consent to the genetic analysis at any time prior to the completionof the analysis;(8)  that the genetic analysis may result in information about the individual's geneticrelatives which may not be known to such relatives but could be important, and if so, theindividual will have to decide whether or not to share that information with relatives;(9)  of the possibility of someone else asking the individual in the future of the existenceof a genetic test or analysis and potentially conditioning a benefit on the disclosure of informationregarding such testing or analysis;(10)  that the collection and analysis of the DNA sample, and the private geneticinformation derived from the analysis is protected by this chapter; and(11)  of the availability of genetic counseling.    26-40-104.Except as provided in Section 26-40-110, no person may analyze an individuallyidentifiable DNA sample without the written informed consent of the individual that is dated andsigned and includes at least the following:(1)  a general description of the test;(2)  the identity of the person who will collect the DNA sample or cause the DNA sampleto be collected;(3)  the facility in which the analysis will be performed;(4)  the manner in which the sample is to be collected;(5)  a description of all authorized uses of the DNA sample;(6)  an indication of whether or not the individual permits the sample to be maintained andstored in an  individually identifiable form after the analysis is complete;(7)  an indication of whether the individual prohibits the use of the DNA sample forresearch or commercial purposes even if the sample is not in an individually identifiable form;(8)  a statement of the purpose of the test, its limitations, and potential uses;(9)  a statement that a positive result is an indication that the individual may be predisposedto or have the specific disease or condition tested for and may wish to consider further independenttesting, consult a physician, or pursue genetic counseling;(10)  a general description of each specific disease or condition tested for;(11)  the level of certainty, if established, that a positive test result for that disease orcondition serves as a predictor of such disease; and(12)  a statement that test results may only be disclosed in accordance with the writtenauthorization of the individual.    26-40-105.(1)  An individually identifiable DNA sample is the property of the individual.(2)  Except when a DNA sample has been collected pursuant to Section 26-40-110:(a)  the individual shall have the right to order the destruction of the DNA sample; and(b)  an individually identifiable DNA sample shall be destroyed on completion of genetic testing authorized by the individual pursuant to Section 26-40-104 unless:(i)  the individual has directed otherwise in writing; or(ii)  all individual identifiers linking the sample to the individual are destroyed.    26-40-106.(1)  Except as provided in Sections 26-40-110 and 26-40-111, no person who, in theordinary course of business, practice of a profession, or rendering of a service, creates, stores,receives, or furnishes private genetic information, may disclose private genetic information toanother person without the prior written authorization of the individual that is dated and signed andincludes at least the following:(a)  the identity of the person authorizing the disclosure;(b)  the identity of the person permitted to make the disclosure;(c)  the identity of each person to whom the information is to be disclosed;(d)  a description of the specific genetic information to be disclosed;(e)  a description of the purpose for which the disclosure is being made;(f)  the expiration date of the authorization, which may not be longer than 30 days after thedate of authorization; and(g)  a statement that the authorization is subject to revocation at any time before thedisclosure is actually made.(2)  A copy of the authorization shall be provided to the person making the authorization.(3)  An individual may revoke or amend the authorization at any time by contacting theperson to whom authorization was given.(4)  An individual may not maintain an action against a person for disclosure of privategenetic information made in good faith reliance on a valid authorization if the person had no noticeof the revocation of the authorization at the time the disclosure was made.(5)  Each disclosure made pursuant to a written authorization described in Subsection (1)must be accompanied by the following written statement: "This information has been disclosedto you from private records protected under the Genetic Testing Privacy Act and any furtherdisclosure of the information without specific authorization from the individual is prohibited."(6)  A general authorization for the release of medical records or medical information maynot be used as a written authorization for the disclosure of private genetic information.    26-40-107.(1)  Except as provided in Subsection (2), an employer may not in connection with a hiring,promotion, retention, or any other employment related decision:(a)  require or request an individual or family member of the individual to take a genetictest;(b)  make any inquiry to determine whether an individual or a blood relative of theindividual has taken or refused to take a genetic test, or what the results of any such test were;(c)  take into consideration the fact that a genetic test was taken or refused to be taken byan individual or blood relative of the individual; or(d)  take into consideration any private genetic information about an individual or a familymember.(2)  Notwithstanding Subsection (1), an employer may consider private genetic informationin connection with an employment decision if the individual, on his own initiative, has voluntarilysubmitted the information and the information is favorable to the individual.    26-40-108.(1)  Except as provided in Subsection (2), a health insurer may not in connection with theoffer or renewal of a health insurance policy or in the determination of premiums, coverage,renewal, or any other matter related to underwriting:(a)  require or request an individual or family member of the individual to take a genetictest;(b)  make any inquiry to determine whether an individual or a blood relative of theindividual has taken or refused to take a genetic test, or what the results of any such test were;(c)  take into consideration the fact that a genetic test was taken or refused to be taken byan individual or family member of the individual; or(d)  take into consideration any private genetic information about an individual or familymember.(2)  Notwithstanding Subsection (1), a health insurer may consider the results of a genetictest in connection with a health insurance policy if the individual, on his own initiative, hasvoluntarily submitted the results and the results are favorable to the individual.    26-40-109.(1)  A life insurer may not collect or cause to be collected, or perform or cause to beperformed a genetic analysis of an individually identifiable DNA sample for the purpose ofdetermining insurability for a life insurance policy without the prior written informed consent ofthe individual as provided in Subsection (2).(2)  Written informed consent under this section shall consist of a writing on a formapproved by the Insurance Commissioner before it is used that is dated and signed and includesat least the following:(a)  a general description of the test;(b)  a statement of the purpose of the test, its limitations, and potential uses;(c)  a statement that a positive result is an indication that the individual may be predisposedto or have the specific disease or condition tested for and may wish to consider further independenttesting, consult a physician, or pursue genetic counseling;(d)  a statement that no tests other than those authorized shall be performed on the DNAsample and that the sample shall be destroyed at the end of the testing process or no more than 60days after the sample was taken;(e)  a statement regarding the manner in which the insurer may use the test results ofgenetic analysis in determining insurability;(f)  a statement that the individual may wish to consult a genetics counselor before takingthe test and whether the insurer will pay for any such consultation;(g)  a statement that the insurer may not require the individual to submit to a genetic testunless the cost of the test is paid for by the insurer;(h)  a statement that the insurer will notify the individual of the results of a genetic testwithin 30 days of receiving them;(i)  a statement that, with the exception of a notation that a genetic test was conducted andany formal action taken as a result of the test, the insurer will destroy all private geneticinformation resulting from a test within 60 days of receiving test results; and(j)  a statement that the insurer may not disclose private genetic information to any thirdparty except for a physician at the individual's written request.    26-40-110.(1)  Notwithstanding any other provision in this chapter, a person may provide access toan individually identifiable DNA sample, or to data derived from DNA typing, to assist in theidentification of a dead body, provided that the analysis of any sample so provided and the analysisof any DNA sample from the dead body is limited to that which is necessary to determine theidentity of the dead body.(2)  Nothing in this chapter may be construed to affect the authority of law enforcementagencies under Title 53, Chapter 5, Part 2, Criminal Identification Act, in collecting, storing,testing, typing, and controlling access to DNA samples in the course of conducting criminalinvestigations.(3)  Nothing in this chapter shall be construed to prohibit the collection or analysis of anindividually identifiable DNA sample pursuant to Title 62A, Chapter 11, Recovery Services, Title78, Chapter 45a, Uniform Act on Paternity, or Rule 35 of the Utah Rules of Civil Procedure, if thegenetic condition of the individual has been placed at issue and the order or agency requestspecifies:(a)  the manner of collection of the DNA sample;(b)  the person or persons authorized to collect and analyze the sample;(c)  the purpose of the genetic analysis;(d)  that the genetic analysis is limited to that which is necessary to fulfill the purpose ofthe order or request; and(e)  that the person conducting the analysis destroy the sample at the earliest possibleopportunity consistent with the purpose of the order or request.    26-40-111.(1)  No person who maintains private genetic information may be compelled to disclosesuch information pursuant to a request for compulsory disclosure in any judicial, legislative, oradministrative proceeding unless:(a)  the person maintaining the genetic information has received the authorization of theindividual to release the information in response to the request for compulsory disclosure;(b)  the individual is a party to the proceeding and the private genetic information is atissue; or(c)  the genetic information is for use in a law enforcement proceeding or investigation inwhich the person maintaining the information is the subject or party.(2) (a)  A person requesting compulsory disclosure pursuant to Subsection (1)(b) or (c)shall serve upon the person maintaining the genetic information and upon the individual:(i)  a copy of the request at least ten days prior to the date on which the compulsorydisclosure is requested; and(ii)  a statement of the right of the individual or person maintaining the genetic informationto have any objections to compulsory disclosure heard by the court or governmental agency priorto the issuance of a compulsory disclosure order, and the procedure to be followed to have anysuch objections heard.(b)  Service under Subsection (2)(a) may be sent by certified mail, return receipt requested,or hand delivered.(3)  Service of a compulsory disclosure request upon a person maintaining private geneticinformation shall be accompanied by a written certification, signed by the person seeking to obtainthe private genetic information or his authorized representative:(a)  identifying at least one subsection of Section (1) under which compulsory disclosureis being sought: and(b)  indicating that the notice requirement of Subsection (2)(a) has been met.(4)  An order under this section may only be entered upon a finding that:(a)  other ways of obtaining the private information are not available or would not beeffective; and(b)  there is a compelling need for the private genetic information which outweighs thepotential harm to the privacy interest of the individual.(5)  An order under this section which authorizes the disclosure of private geneticinformation shall:(a)  limit disclosure to those parts of the record containing such information which areessential to fulfill the objective of the order;(b)  limit disclosure to those persons whose need for the information is the basis of theorder; and(c)  include such other measures as may be necessary to limit disclosure for the protectionof the individual.    26-40-112.(1)  No individually identifiable DNA sample may be analyzed as part of a research projectunless an Institutional Review Board has determined that:(a)  use of individually identifiable DNA samples is essential to the research project;(b)  the potential benefit of the research project outweighs the potential risks to researchsubjects, including psychosocial risks and intrusion into privacy of the subjects that would resultfrom analysis of individually identifiable samples;(c)  the research protocol:(i)  requires that research subjects will be given the information set forth in Section26-40-103;(ii)  requires the written authorization of research subjects that includes the requirementsof Section 26-40-104;(iii)  prohibits inclusion of research records in medical records unless the research subjectauthorizes such inclusion in writing; and(iv)  contains adequate safeguards to protect against disclosure of private geneticinformation that is generated by the research, including:(A)  ensuring that research subjects will not be identifiable in any report or publicationwhich results from the research; and(B)  having procedures to remove or destroy at the earliest opportunity consistent with thepurposes of the project, information that would enable a research subject to be identified.(2) (a)  In the absence of a specific authorization to maintain an individually identifiableDNA sample, individually identifiable DNA samples collected, stored, or analyzed in connectionwith a research project shall be destroyed upon completion of the project or withdrawal of theresearch subject from the project, whichever occurs first, unless Subsection (2)(b) applies.(b)  Whenever the authorization for collection, storage, or analysis of an individuallyidentifiable DNA sample does not contain a prohibition against research use of the sample whenit is no longer linked to an individual identifier, the person in possession of the sample may destroyall individual identifiers linking the sample to the individual instead of destroying the sample asrequired by Subsection (2)(a).(3)  When a research project includes analysis of DNA from family members for pedigreeanalysis or linkage analysis:(a)  the Institutional Review Board, in addition to making the determinations required inSubsection (1), shall require:(i)  that education and counseling regarding how pedigree analysis is conducted and thekind of information that results from such analysis is provided to research subjects; and(ii)  that as far as practicable separate records are maintained on each subject; and(b)  a research subject, prior to participation and in addition to the disclosures required bySection 26-40-103, shall be informed:(i)  that one risk of participation is that by the end of the project other family members maylearn private genetic information about the individual;(ii)  of what will be done with records and data generated during the project; and(iii)  that the project may determine that some family members are not genetic relatives.(4)  Nothing in this chapter may be construed to prohibit or limit research on a DNAsample that cannot be linked to any individual identifier.    26-40-113.(1)  Except as provided in Subsection (2), no person may allow a researcher to accessprivate genetic information unless:(a)  an Institutional Review Board has approved the conduct of the research program orstudy; and(b)  the individual has specifically consented to the access or disclosure of the informationin an authorization that meets the requirements of Section 26-40-106.(2)  A person may grant access to private genetic information solely for the purpose ofinspection or review of records containing the information provided that:(a)  the inspection or review is for the purpose of compiling data for statistical orepidemiological studies and private genetic information is not to be copied, removed from therecords, or redisclosed in any way; and(b)  the person conducting the inspection or review certifies in writing:(i)  that these limitations will be complied with; and(ii)  to an awareness of their liability for violations of this chapter.    26-40-114.(1)  Any person who, prior to July 1, 1998, is in possession of an individually identifiableDNA sample shall, prior to performing any genetic analysis on the DNA samples:(a)  make the disclosures required by Section 26-40-103; and(b)  obtain a written authorization that meets the requirements of Section 26-40-104; or(c)  take all necessary steps to ensure that the DNA sample is no longer linked to anyindividual identifier.(2)  An authorization for the disclosure of private genetic information that is executedbefore July 1, 1998, and which does not meet the requirements of Section 26-40-106, shall remainvalid until August 1, 1998, or the expiration date specified in the authorization, whichever occursearlier.    26-40-115.(1)  Any person whose rights under this chapter have been violated may maintain a civilaction for damages and equitable relief.(2)  Any person who through negligence collects or analyzes a DNA sample in violationof this chapter, or discloses private genetic information in violation of this chapter, shall be liableto the individual for each violation in an amount equal to:(a)  actual damages sustained as a result of the violation or $5,000, whichever is greater;(b)  treble damages, if the violation resulted in profit or monetary gain; and(c)  reasonable attorneys' fees and costs.(3)  Any person who through a request, the use of persuasion, under threat, or with apromise of reward, willfully induces a person to collect or analyze a DNA sample in violation ofthis chapter or to disclose private genetic information in violation of this chapter, or who, himself,willfully collects or analyzes a DNA sample in violation of this chapter, or willfully disclosesprivate genetic information in violation of this chapter shall be liable to the individual for eachviolation in an amount equal to:(a)  actual damages sustained as a result of the violation or $15,000, whichever is greater;(b)  punitive damages as the court may allow; and(c)  reasonable attorneys' fees and costs.    26-40-116.(1)  Whenever the attorney general has reason to believe that any person is using or is aboutto use any method, act, or practice in violation of the provisions of this chapter, and thatproceedings would be in the public interest, the attorney general may bring an action against theperson to restrain or enjoin the use of such method, act, or practice.(2)  In addition to restraining or enjoining the use of a method, act, or practice, the courtmay require the payment of:(a)  a civil fine of not more than $25,000 for each violation; and(b)  reasonable costs of investigation and litigation, including reasonable attorneys' fees.    31A-22-424.Except as provided in Section 26-40-109, a life insurer may not collect or cause to becollected, or perform or cause to be performed a genetic analysis of an individually identifiableDNA sample for the purpose of determining insurability for a life insurance policy.    31A-22-623.Except as provided in Section 26-40-108, an insurer may not in connection with the offeror renewal of a disability policy or in the determination of premiums, coverage, renewal, or anyother matter related to underwriting:(1)  require or request an individual or family member of the individual to take a genetictest;(2)  make any inquiry to determine whether an individual or a blood relative of theindividual has taken or refused to take a genetic test, or what the results of any such test were;(3)  take into consideration the fact that a genetic test was taken or refused to be taken byan individual or family member of the individual; or(4)  take into consideration any private genetic information about an individual or familymember.    34A-5-201.This part is known as the "Genetic Testing Restrictions on Employers Act."    34A-5-202.Except as provided in Section 26-40-107, an employer, as defined in Section 34A-2-103,may not in connection with a hiring, promotion, retention, or any other employment-relateddecision:(1)  require or request an individual or family member of the individual to take a genetictest;(2)  make any inquiry to determine whether an individual or a blood relative of theindividual has taken or refused to take a genetic test, or what the results of any such test were;(3)  take into consideration the fact that a genetic test was taken or refused to be taken byan individual or family member of the individual; or(4)  take into consideration any private genetic information about an individual or familymember.and Title 26, Chapter 40,Genetic Testing Privacy Act(2)(8); and(vi)  requires that the researcher complies with the provisions of Title 26, Chapter 40,Genetic Testing Privacy Act, if the research involves genetic information.genetic information,This act takes effect on July 1, 1998.Full text:



Utah State Legislature












Legislators

By Session (1896-Current)
Alphabetical (Historical)
Find by Address/Map
More


Bills

Bills/Bill Requests
Passed Bills
2017 Bills

Keyword Search
Reading Calendars
Tracking Service
More


Committees

All Committees
Appropriations
Commissions

Independent Legislative Ethics Commission
Interim
Standing
Subcommittees
Task Forces
Bills In Committees


Utah Code / Constitution


Title/Chapter/Section
Keyword Search 

Utah Constitution
Laws of Utah 1851-ongoing
Utah Territorial Laws 
More


Senate

Main Page 
About The Senate 
Leadership 
Roster 
Seating Chart 
District Maps 
Extraordinary Sessions 
Reading Calendars 
Past Floor Debates 
Senate Journals 


House

Main Page
About the House 
Leadership 
Roster 
Seating Chart 
District Maps 
Reading Calendars 
Past Floor Debates 
Journals 
Conflict of Interest Forms 


Legislative Guide 

Legislative Guide
Civic Programs
GRAMA (Records Requests)


Publications

Search Publications
Appropriations
Audits
Bagels & Briefings
Briefing Papers
Digest of Legislation
Legislative Drafting Manual

Journals

Interim Highlights

Legislative Rules
GRAMA (Records Requests)
Public Email
State Organization Charts
YouTube Channel
Requests for Proposals and Legal Notices
More


Legislative Histories

Legislative History Resources
How to Research
Bill Drafting/Research Files (1990-Ongoing)

Working Bills (1896-1989)
Interim Committee Histories (1990-Ongoing) 
Journals
Past House Floor Debates
Past Senate Floor Debates
More


Staff Offices

All Legislative Offices
Auditor General
Fiscal Analyst
Printing
Research and General Counsel
Staff Awards
Job Opportunities
More


Links of Interest

Utah Administrative Rules
Courts
Utah State Capitol
State of Utah
Federal Legislation
More






 

Download Zipped Introduced WP 6.1 HB0271.ZIP 26,877 Bytes
[Status][Bill Documents][Fiscal Note][Bills Directory]


H.B. 271









1     GENETIC TESTING PRIVACY ACT




2    1998 GENERAL SESSION


3    STATE OF UTAH


4     Sponsor:  Nora B. Stephens


5    AN ACT RELATING TO HEALTH; ENACTING THE GENETIC TESTING PRIVACY ACT;

6    DEFINING TERMS; REQUIRING VERBAL DISCLOSURE AND WRITTEN CONSENT

7    PRIOR TO COLLECTING AND ANALYZING A DNA SAMPLE; REQUIRING WRITTEN

8    CONSENT TO DISCLOSE PRIVATE GENETIC INFORMATION; ESTABLISHING

9    OWNERSHIP OF A DNA SAMPLE AND PROCEDURES FOR DESTROYING THE

10    SAMPLE; PLACING SPECIAL RESTRICTIONS ON EMPLOYERS AND INSURERS;

11    ESTABLISHING EXCEPTIONS TO THE REQUIREMENT OF INFORMED CONSENT

12    AND PERMITTING COMPELLED DISCLOSURE OF PRIVATE GENETIC

13    INFORMATION IN LIMITED CIRCUMSTANCES; SPECIFYING THE USE OF

14    INDIVIDUALLY IDENTIFYING DNA SAMPLES IN RESEARCH ACTIVITIES;

15    ESTABLISHING GUIDELINES FOR THE TREATMENT OF PREVIOUSLY COLLECTED

16    DNA SAMPLES; PROVIDING A PRIVATE RIGHT OF ACTION FOR VIOLATIONS;

17    AUTHORIZING THE ATTORNEY GENERAL TO ENFORCE THE ACT; AND

18    PROVIDING AN EFFECTIVE DATE.

19    This act affects sections of Utah Code Annotated 1953 as follows:

20    AMENDS:

21         63-2-202, as last amended by Chapter 312, Laws of Utah 1994

22         63-2-302, as last amended by Chapter 232, Laws of Utah 1997

23    ENACTS:

24         26-40-101, Utah Code Annotated 1953

25         26-40-102, Utah Code Annotated 1953

26         26-40-103, Utah Code Annotated 1953

27         26-40-104, Utah Code Annotated 1953


1         26-40-105, Utah Code Annotated 1953

2         26-40-106, Utah Code Annotated 1953

3         26-40-107, Utah Code Annotated 1953

4         26-40-108, Utah Code Annotated 1953

5         26-40-109, Utah Code Annotated 1953

6         26-40-110, Utah Code Annotated 1953

7         26-40-111, Utah Code Annotated 1953

8         26-40-112, Utah Code Annotated 1953

9         26-40-113, Utah Code Annotated 1953

10         26-40-114, Utah Code Annotated 1953

11         26-40-115, Utah Code Annotated 1953

12         26-40-116, Utah Code Annotated 1953

13         31A-22-424, Utah Code Annotated 1953

14         31A-22-623, Utah Code Annotated 1953

15         34A-5-201, Utah Code Annotated 1953

16         34A-5-202, Utah Code Annotated 1953

17    Be it enacted by the Legislature of the state of Utah:

18        Section 1.  Section  26-40-101 is enacted to read:

19     CHAPTER 40.  GENETIC TESTING PRIVACY ACT


20         26-40-101.  Title.

21        This chapter is known as the "Genetic Testing Privacy Act."

22        Section 2.  Section  26-40-102 is enacted to read:

23         26-40-102.  Definitions.

24        As used in this chapter:

25        (1)  "Compulsory disclosure" means any disclosure of genetic information mandated or

26    required by federal or state law in connection with a judicial, legislative, or administrative

27    proceeding.

28        (2)  "Disclose" or "disclosure" means to convey or to provide access to private genetic

29    information to a person other than the individual.

30        (3)  "DNA" means deoxyribonucleic acid.

31        (4)  "DNA sample" means any human biological specimen from which DNA can be

- 2 -


1    extracted, or DNA extracted from such specimen.

2        (5)  "DNA typing" means a scientifically reliable method for characterizing and comparing

3    sequences of DNA, and applying a statistical analysis of population frequency to determine that

4    if the DNA sequences match, the probability that the match occurs by chance.

5        (6)  "Employer" is as defined in Section 34A-2-103.

6        (7)  "Genetic test" means the analysis of an individually identifiable DNA sample.

7        (8)  "Health insurer" means an insurer, as defined in Section 31A-1-301, who offers

8    insurance governed by Title 31A, Chapter 22, Part VI, Disability Insurance.

9        (9)  "Identifiable individual" means any individual whose name, address, Social Security

10    number, health insurance identification number, or similar identifying information is known,

11    available, or can be determined with reasonable accuracy either directly or by reference to other

12    information.

13        (10)  "Individual" means:

14        (a)  the person from whose body the DNA sample originated;

15        (b)  a person who is authorized to make health care decisions concerning a minor or an

16    incompetent person from whose body or DNA sample originated; or

17        (c)  the administrator or executor of a deceased person's estate, if any, otherwise the next

18    of kin of a deceased person from whose body a DNA sample originated.

19        (11)  "Individual identifier" means a name, address, Social Security number, health

20    insurance identification number, or similar information by which the identity of an individual can

21    be determined with reasonable accuracy, either directly or by reference to other available

22    information.  The term does not include characters, number, or codes assigned to an individual or

23    a DNA sample which cannot be used to determine the individual's identity.

24        (12)  "Institutional Review Board" means a board established in accordance with 45 CFR

25    46.102(g)(1992) as such regulation may be amended.

26        (13)  "Life insurer" means an insurer, as defined in Section 31A-1-301, who offers

27    insurance governed by Title 31A, Chapter 22, Part IV, Life Insurance and Annuities.

28        (14)  "Person" means all persons, organizations, and entities other than the individual.

29        (15)  "Private genetic information" means any information about an identifiable individual

30    that is derived from the presence, absence, alteration, or mutation of a gene or genes, or the

31    presence or absence of a specific DNA marker or markers, and which has been obtained:

- 3 -


1        (a)  from a test or analysis of the individual's DNA; or

2        (b)  from a test or analysis of a person to whom the individual is related.

3        (16)  "Research subject" means:

4        (a)  a person whose DNA sample is analyzed as part of a research project;

5        (b)  a person who is authorized to make health care decisions concerning a minor or

6    incompetent person whose DNA sample is analyzed as part of a research project; or

7        (c)  the administrator or executor of a deceased person's estate, if any, otherwise the next

8    of kin of a deceased person whose DNA sample is analyzed as part of a research project.

9        Section 3.  Section  26-40-103 is enacted to read:

10         26-40-103.  Collection of DNA samples.

11        Except as provided in Section 26-40-110, no person may collect or cause to be collected

12    an individually identifiable DNA sample for genetic analysis without verbally informing the

13    individual:

14        (1)  that consent to the collection and the taking of the DNA is voluntary;

15        (2)  that consent to the genetic analysis is voluntary;

16        (3)  of the information that can be reasonably expected to be derived from the genetic

17    analysis;

18        (4)  of the use, if any, that the individual will be able to make of the information derived

19    from the genetic analysis;

20        (5)  of the right to inspect records that contain information derived from the genetic

21    analysis;

22        (6)  of the right to have the DNA sample destroyed;

23        (7)  of the right to revoke consent to the genetic analysis at any time prior to the completion

24    of the analysis;

25        (8)  that the genetic analysis may result in information about the individual's genetic

26    relatives which may not be known to such relatives but could be important, and if so, the

27    individual will have to decide whether or not to share that information with relatives;

28        (9)  of the possibility of someone else asking the individual in the future of the existence

29    of a genetic test or analysis and potentially conditioning a benefit on the disclosure of information

30    regarding such testing or analysis;

31        (10)  that the collection and analysis of the DNA sample, and the private genetic

- 4 -


1    information derived from the analysis is protected by this chapter; and

2        (11)  of the availability of genetic counseling.

3        Section 4.  Section  26-40-104 is enacted to read:

4         26-40-104.  Analysis of DNA samples.

5        Except as provided in Section 26-40-110, no person may analyze an individually

6    identifiable DNA sample without the written informed consent of the individual that is dated and

7    signed and includes at least the following:

8        (1)  a general description of the test;

9        (2)  the identity of the person who will collect the DNA sample or cause the DNA sample

10    to be collected;

11        (3)  the facility in which the analysis will be performed;

12        (4)  the manner in which the sample is to be collected;

13        (5)  a description of all authorized uses of the DNA sample;

14        (6)  an indication of whether or not the individual permits the sample to be maintained and

15    stored in an  individually identifiable form after the analysis is complete;

16        (7)  an indication of whether the individual prohibits the use of the DNA sample for

17    research or commercial purposes even if the sample is not in an individually identifiable form;

18        (8)  a statement of the purpose of the test, its limitations, and potential uses;

19        (9)  a statement that a positive result is an indication that the individual may be predisposed

20    to or have the specific disease or condition tested for and may wish to consider further independent

21    testing, consult a physician, or pursue genetic counseling;

22        (10)  a general description of each specific disease or condition tested for;

23        (11)  the level of certainty, if established, that a positive test result for that disease or

24    condition serves as a predictor of such disease; and

25        (12)  a statement that test results may only be disclosed in accordance with the written

26    authorization of the individual.

27        Section 5.  Section  26-40-105 is enacted to read:

28         26-40-105.  Ownership and destruction of DNA samples.

29        (1)  An individually identifiable DNA sample is the property of the individual.

30        (2)  Except when a DNA sample has been collected pursuant to Section 26-40-110:

31        (a)  the individual shall have the right to order the destruction of the DNA sample; and

- 5 -


1        (b)  an individually identifiable DNA sample shall be destroyed on completion of genetic 

2    testing authorized by the individual pursuant to Section 26-40-104 unless:

3        (i)  the individual has directed otherwise in writing; or

4        (ii)  all individual identifiers linking the sample to the individual are destroyed.

5        Section 6.  Section  26-40-106 is enacted to read:

6         26-40-106.  Disclosure of private genetic information.

7        (1)  Except as provided in Sections 26-40-110 and 26-40-111, no person who, in the

8    ordinary course of business, practice of a profession, or rendering of a service, creates, stores,

9    receives, or furnishes private genetic information, may disclose private genetic information to

10    another person without the prior written authorization of the individual that is dated and signed and

11    includes at least the following:

12        (a)  the identity of the person authorizing the disclosure;

13        (b)  the identity of the person permitted to make the disclosure;

14        (c)  the identity of each person to whom the information is to be disclosed;

15        (d)  a description of the specific genetic information to be disclosed;

16        (e)  a description of the purpose for which the disclosure is being made;

17        (f)  the expiration date of the authorization, which may not be longer than 30 days after the

18    date of authorization; and

19        (g)  a statement that the authorization is subject to revocation at any time before the

20    disclosure is actually made.

21        (2)  A copy of the authorization shall be provided to the person making the authorization.

22        (3)  An individual may revoke or amend the authorization at any time by contacting the

23    person to whom authorization was given.

24        (4)  An individual may not maintain an action against a person for disclosure of private

25    genetic information made in good faith reliance on a valid authorization if the person had no notice

26    of the revocation of the authorization at the time the disclosure was made.

27        (5)  Each disclosure made pursuant to a written authorization described in Subsection (1)

28    must be accompanied by the following written statement: "This information has been disclosed

29    to you from private records protected under the Genetic Testing Privacy Act and any further

30    disclosure of the information without specific authorization from the individual is prohibited."

31        (6)  A general authorization for the release of medical records or medical information may

- 6 -


1    not be used as a written authorization for the disclosure of private genetic information.

2        Section 7.  Section  26-40-107 is enacted to read:

3         26-40-107.  Restrictions on employers.

4        (1)  Except as provided in Subsection (2), an employer may not in connection with a hiring,

5    promotion, retention, or any other employment related decision:

6        (a)  require or request an individual or family member of the individual to take a genetic

7    test;

8        (b)  make any inquiry to determine whether an individual or a blood relative of the

9    individual has taken or refused to take a genetic test, or what the results of any such test were;

10        (c)  take into consideration the fact that a genetic test was taken or refused to be taken by

11    an individual or blood relative of the individual; or

12        (d)  take into consideration any private genetic information about an individual or a family

13    member.

14        (2)  Notwithstanding Subsection (1), an employer may consider private genetic information

15    in connection with an employment decision if the individual, on his own initiative, has voluntarily

16    submitted the information and the information is favorable to the individual.

17        Section 8.  Section  26-40-108 is enacted to read:

18         26-40-108.  Restrictions on health insurers.

19        (1)  Except as provided in Subsection (2), a health insurer may not in connection with the

20    offer or renewal of a health insurance policy or in the determination of premiums, coverage,

21    renewal, or any other matter related to underwriting:

22        (a)  require or request an individual or family member of the individual to take a genetic

23    test;

24        (b)  make any inquiry to determine whether an individual or a blood relative of the

25    individual has taken or refused to take a genetic test, or what the results of any such test were;

26        (c)  take into consideration the fact that a genetic test was taken or refused to be taken by

27    an individual or family member of the individual; or

28        (d)  take into consideration any private genetic information about an individual or family

29    member.

30        (2)  Notwithstanding Subsection (1), a health insurer may consider the results of a genetic

31    test in connection with a health insurance policy if the individual, on his own initiative, has

- 7 -


1    voluntarily submitted the results and the results are favorable to the individual.

2        Section 9.  Section  26-40-109 is enacted to read:

3         26-40-109.  Restrictions on life insurers.

4        (1)  A life insurer may not collect or cause to be collected, or perform or cause to be

5    performed a genetic analysis of an individually identifiable DNA sample for the purpose of

6    determining insurability for a life insurance policy without the prior written informed consent of

7    the individual as provided in Subsection (2).

8        (2)  Written informed consent under this section shall consist of a writing on a form

9    approved by the Insurance Commissioner before it is used that is dated and signed and includes

10    at least the following:

11        (a)  a general description of the test;

12        (b)  a statement of the purpose of the test, its limitations, and potential uses;

13        (c)  a statement that a positive result is an indication that the individual may be predisposed

14    to or have the specific disease or condition tested for and may wish to consider further independent

15    testing, consult a physician, or pursue genetic counseling;

16        (d)  a statement that no tests other than those authorized shall be performed on the DNA

17    sample and that the sample shall be destroyed at the end of the testing process or no more than 60

18    days after the sample was taken;

19        (e)  a statement regarding the manner in which the insurer may use the test results of

20    genetic analysis in determining insurability;

21        (f)  a statement that the individual may wish to consult a genetics counselor before taking

22    the test and whether the insurer will pay for any such consultation;

23        (g)  a statement that the insurer may not require the individual to submit to a genetic test

24    unless the cost of the test is paid for by the insurer;

25        (h)  a statement that the insurer will notify the individual of the results of a genetic test

26    within 30 days of receiving them;

27        (i)  a statement that, with the exception of a notation that a genetic test was conducted and

28    any formal action taken as a result of the test, the insurer will destroy all private genetic

29    information resulting from a test within 60 days of receiving test results; and

30        (j)  a statement that the insurer may not disclose private genetic information to any third

31    party except for a physician at the individual's written request.

- 8 -


1        Section 10.  Section  26-40-110 is enacted to read:

2         26-40-110.  Exceptions to informed consent.

3        (1)  Notwithstanding any other provision in this chapter, a person may provide access to

4    an individually identifiable DNA sample, or to data derived from DNA typing, to assist in the

5    identification of a dead body, provided that the analysis of any sample so provided and the analysis

6    of any DNA sample from the dead body is limited to that which is necessary to determine the

7    identity of the dead body.

8        (2)  Nothing in this chapter may be construed to affect the authority of law enforcement

9    agencies under Title 53, Chapter 5, Part 2, Criminal Identification Act, in collecting, storing,

10    testing, typing, and controlling access to DNA samples in the course of conducting criminal

11    investigations.

12        (3)  Nothing in this chapter shall be construed to prohibit the collection or analysis of an

13    individually identifiable DNA sample pursuant to Title 62A, Chapter 11, Recovery Services, Title

14    78, Chapter 45a, Uniform Act on Paternity, or Rule 35 of the Utah Rules of Civil Procedure, if the

15    genetic condition of the individual has been placed at issue and the order or agency request

16    specifies:

17        (a)  the manner of collection of the DNA sample;

18        (b)  the person or persons authorized to collect and analyze the sample;

19        (c)  the purpose of the genetic analysis;

20        (d)  that the genetic analysis is limited to that which is necessary to fulfill the purpose of

21    the order or request; and

22        (e)  that the person conducting the analysis destroy the sample at the earliest possible

23    opportunity consistent with the purpose of the order or request.

24        Section 11.  Section  26-40-111 is enacted to read:

25         26-40-111.  Compulsory disclosure of private genetic information.

26        (1)  No person who maintains private genetic information may be compelled to disclose

27    such information pursuant to a request for compulsory disclosure in any judicial, legislative, or

28    administrative proceeding unless:

29        (a)  the person maintaining the genetic information has received the authorization of the

30    individual to release the information in response to the request for compulsory disclosure;

31        (b)  the individual is a party to the proceeding and the private genetic information is at

- 9 -


1    issue; or

2        (c)  the genetic information is for use in a law enforcement proceeding or investigation in

3    which the person maintaining the information is the subject or party.

4        (2) (a)  A person requesting compulsory disclosure pursuant to Subsection (1)(b) or (c)

5    shall serve upon the person maintaining the genetic information and upon the individual:

6        (i)  a copy of the request at least ten days prior to the date on which the compulsory

7    disclosure is requested; and

8        (ii)  a statement of the right of the individual or person maintaining the genetic information

9    to have any objections to compulsory disclosure heard by the court or governmental agency prior

10    to the issuance of a compulsory disclosure order, and the procedure to be followed to have any

11    such objections heard.

12        (b)  Service under Subsection (2)(a) may be sent by certified mail, return receipt requested,

13    or hand delivered.

14        (3)  Service of a compulsory disclosure request upon a person maintaining private genetic

15    information shall be accompanied by a written certification, signed by the person seeking to obtain

16    the private genetic information or his authorized representative:

17        (a)  identifying at least one subsection of Section (1) under which compulsory disclosure

18    is being sought: and

19        (b)  indicating that the notice requirement of Subsection (2)(a) has been met.

20        (4)  An order under this section may only be entered upon a finding that:

21        (a)  other ways of obtaining the private information are not available or would not be

22    effective; and

23        (b)  there is a compelling need for the private genetic information which outweighs the

24    potential harm to the privacy interest of the individual.

25        (5)  An order under this section which authorizes the disclosure of private genetic

26    information shall:

27        (a)  limit disclosure to those parts of the record containing such information which are

28    essential to fulfill the objective of the order;

29        (b)  limit disclosure to those persons whose need for the information is the basis of the

30    order; and

31        (c)  include such other measures as may be necessary to limit disclosure for the protection

- 10 -


1    of the individual.

2        Section 12.  Section  26-40-112 is enacted to read:

3         26-40-112.  Research activities involving genetic analysis.

4        (1)  No individually identifiable DNA sample may be analyzed as part of a research project

5    unless an Institutional Review Board has determined that:

6        (a)  use of individually identifiable DNA samples is essential to the research project;

7        (b)  the potential benefit of the research project outweighs the potential risks to research

8    subjects, including psychosocial risks and intrusion into privacy of the subjects that would result

9    from analysis of individually identifiable samples;

10        (c)  the research protocol:

11        (i)  requires that research subjects will be given the information set forth in Section

12    26-40-103;

13        (ii)  requires the written authorization of research subjects that includes the requirements

14    of Section 26-40-104;

15        (iii)  prohibits inclusion of research records in medical records unless the research subject

16    authorizes such inclusion in writing; and

17        (iv)  contains adequate safeguards to protect against disclosure of private genetic

18    information that is generated by the research, including:

19        (A)  ensuring that research subjects will not be identifiable in any report or publication

20    which results from the research; and

21        (B)  having procedures to remove or destroy at the earliest opportunity consistent with the

22    purposes of the project, information that would enable a research subject to be identified.

23        (2) (a)  In the absence of a specific authorization to maintain an individually identifiable

24    DNA sample, individually identifiable DNA samples collected, stored, or analyzed in connection

25    with a research project shall be destroyed upon completion of the project or withdrawal of the

26    research subject from the project, whichever occurs first, unless Subsection (2)(b) applies.

27        (b)  Whenever the authorization for collection, storage, or analysis of an individually

28    identifiable DNA sample does not contain a prohibition against research use of the sample when

29    it is no longer linked to an individual identifier, the person in possession of the sample may destroy

30    all individual identifiers linking the sample to the individual instead of destroying the sample as

31    required by Subsection (2)(a).

- 11 -


1        (3)  When a research project includes analysis of DNA from family members for pedigree

2    analysis or linkage analysis:

3        (a)  the Institutional Review Board, in addition to making the determinations required in

4    Subsection (1), shall require:

5        (i)  that education and counseling regarding how pedigree analysis is conducted and the

6    kind of information that results from such analysis is provided to research subjects; and

7        (ii)  that as far as practicable separate records are maintained on each subject; and

8        (b)  a research subject, prior to participation and in addition to the disclosures required by

9    Section 26-40-103, shall be informed:

10        (i)  that one risk of participation is that by the end of the project other family members may

11    learn private genetic information about the individual;

12        (ii)  of what will be done with records and data generated during the project; and

13        (iii)  that the project may determine that some family members are not genetic relatives.

14        (4)  Nothing in this chapter may be construed to prohibit or limit research on a DNA

15    sample that cannot be linked to any individual identifier.

16        Section 13.  Section  26-40-113 is enacted to read:

17         26-40-113.  Disclosure of private genetic information for research purposes.

18        (1)  Except as provided in Subsection (2), no person may allow a researcher to access

19    private genetic information unless:

20        (a)  an Institutional Review Board has approved the conduct of the research program or

21    study; and

22        (b)  the individual has specifically consented to the access or disclosure of the information

23    in an authorization that meets the requirements of Section 26-40-106.

24        (2)  A person may grant access to private genetic information solely for the purpose of

25    inspection or review of records containing the information provided that:

26        (a)  the inspection or review is for the purpose of compiling data for statistical or

27    epidemiological studies and private genetic information is not to be copied, removed from the

28    records, or redisclosed in any way; and

29        (b)  the person conducting the inspection or review certifies in writing:

30        (i)  that these limitations will be complied with; and

31        (ii)  to an awareness of their liability for violations of this chapter.

- 12 -


1        Section 14.  Section  26-40-114 is enacted to read:

2         26-40-114.  DNA samples collected prior to July 1, 1998.

3        (1)  Any person who, prior to July 1, 1998, is in possession of an individually identifiable

4    DNA sample shall, prior to performing any genetic analysis on the DNA samples:

5        (a)  make the disclosures required by Section 26-40-103; and

6        (b)  obtain a written authorization that meets the requirements of Section 26-40-104; or

7        (c)  take all necessary steps to ensure that the DNA sample is no longer linked to any

8    individual identifier.

9        (2)  An authorization for the disclosure of private genetic information that is executed

10    before July 1, 1998, and which does not meet the requirements of Section 26-40-106, shall remain

11    valid until August 1, 1998, or the expiration date specified in the authorization, whichever occurs

12    earlier.

13        Section 15.  Section  26-40-115 is enacted to read:

14         26-40-115.  Private right of action.

15        (1)  Any person whose rights under this chapter have been violated may maintain a civil

16    action for damages and equitable relief.

17        (2)  Any person who through negligence collects or analyzes a DNA sample in violation

18    of this chapter, or discloses private genetic information in violation of this chapter, shall be liable

19    to the individual for each violation in an amount equal to:

20        (a)  actual damages sustained as a result of the violation or $5,000, whichever is greater;

21        (b)  treble damages, if the violation resulted in profit or monetary gain; and

22        (c)  reasonable attorneys' fees and costs.

23        (3)  Any person who through a request, the use of persuasion, under threat, or with a

24    promise of reward, willfully induces a person to collect or analyze a DNA sample in violation of

25    this chapter or to disclose private genetic information in violation of this chapter, or who, himself,

26    willfully collects or analyzes a DNA sample in violation of this chapter, or willfully discloses

27    private genetic information in violation of this chapter shall be liable to the individual for each

28    violation in an amount equal to:

29        (a)  actual damages sustained as a result of the violation or $15,000, whichever is greater;

30        (b)  punitive damages as the court may allow; and

31        (c)  reasonable attorneys' fees and costs.

- 13 -


1        Section 16.  Section  26-40-116 is enacted to read:

2         26-40-116.  Enforcement.

3        (1)  Whenever the attorney general has reason to believe that any person is using or is about

4    to use any method, act, or practice in violation of the provisions of this chapter, and that

5    proceedings would be in the public interest, the attorney general may bring an action against the

6    person to restrain or enjoin the use of such method, act, or practice.

7        (2)  In addition to restraining or enjoining the use of a method, act, or practice, the court

8    may require the payment of:

9        (a)  a civil fine of not more than $25,000 for each violation; and

10        (b)  reasonable costs of investigation and litigation, including reasonable attorneys' fees.

11        Section 17.  Section  31A-22-424 is enacted to read:

12         31A-22-424.  Genetic testing restrictions.

13        Except as provided in Section 26-40-109, a life insurer may not collect or cause to be

14    collected, or perform or cause to be performed a genetic analysis of an individually identifiable

15    DNA sample for the purpose of determining insurability for a life insurance policy.

16        Section 18.  Section  31A-22-623 is enacted to read:

17         31A-22-623.  Genetic testing restrictions.

18        Except as provided in Section 26-40-108, an insurer may not in connection with the offer

19    or renewal of a disability policy or in the determination of premiums, coverage, renewal, or any

20    other matter related to underwriting:

21        (1)  require or request an individual or family member of the individual to take a genetic

22    test;

23        (2)  make any inquiry to determine whether an individual or a blood relative of the

24    individual has taken or refused to take a genetic test, or what the results of any such test were;

25        (3)  take into consideration the fact that a genetic test was taken or refused to be taken by

26    an individual or family member of the individual; or

27        (4)  take into consideration any private genetic information about an individual or family

28    member.

29        Section 19.  Section  34A-5-201 is enacted to read:

30     Part 2.  Genetic Testing Restrictions


31         34A-5-201.  Title.

- 14 -


1        This part is known as the "Genetic Testing Restrictions on Employers Act."

2        Section 20.  Section  34A-5-202 is enacted to read:

3         34A-5-202.  Genetic testing restrictions.

4        Except as provided in Section 26-40-107, an employer, as defined in Section 34A-2-103,

5    may not in connection with a hiring, promotion, retention, or any other employment-related

6    decision:

7        (1)  require or request an individual or family member of the individual to take a genetic

8    test;

9        (2)  make any inquiry to determine whether an individual or a blood relative of the

10    individual has taken or refused to take a genetic test, or what the results of any such test were;

11        (3)  take into consideration the fact that a genetic test was taken or refused to be taken by

12    an individual or family member of the individual; or

13        (4)  take into consideration any private genetic information about an individual or family

14    member.

15        Section 21.  Section  63-2-202 is amended to read:

16         63-2-202.  Access to private, controlled, and protected documents.  

17        (1)  Upon request, a governmental entity shall disclose a private record to:

18        (a)  the subject of the record;

19        (b)  the parent or legal guardian of an unemancipated minor who is the subject of the

20    record;

21        (c)  the legal guardian of a legally incapacitated individual who is the subject of the record;

22        (d)  any other individual who:

23        (i)  has a power of attorney from the subject of the record;

24        (ii)  submits a notarized release from the subject of the record or his legal representative

25    dated no more than 90 days before the date the request is made; or

26        (iii)  if the record is a medical record described in Subsection 63-2-302(1)(b), is a health

27    care provider, as defined in Subsection 26-33a-102(7), if releasing the record or information in the

28    record is consistent with normal professional practice and medical ethics and Title 26, Chapter 40,

29    Genetic Testing Privacy Act; or

30        (e)  any person to whom the record must be provided pursuant to court order as provided

31    in Subsection (7) or a legislative subpoena as provided in Title 36, Chapter 14.

- 15 -


1        (2) (a)  Upon request, a governmental entity shall disclose a controlled record to:

2        (i)  a physician, psychologist, certified social worker, insurance provider or agent, or a

3    government public health agency upon submission of a release from the subject of the record that

4    is dated no more than 90 days prior to the date the request is made and a signed acknowledgment

5    of the terms of disclosure of controlled information as provided by Subsection (2)(b); and

6        (ii)  any person to whom the record must be disclosed pursuant to court order as provided

7    in Subsection (7) or a legislative subpoena as provided in Title 36, Chapter 14.

8        (b)  A person who receives a record from a governmental entity in accordance with

9    Subsection (2)(a)(i) may not disclose controlled information from that record to any person,

10    including the subject of the record.

11        (3)  If there is more than one subject of a private or controlled record, the portion of the

12    record that pertains to another subject shall be segregated from the portion that the requester is

13    entitled to inspect.

14        (4)  Upon request, a governmental entity shall disclose a protected record to:

15        (a)  the person who submitted the record;

16        (b)  any other individual who:

17        (i)  has a power of attorney from all persons, governmental entities, or political

18    subdivisions whose interests were sought to be protected by the protected classification; or

19        (ii)  submits a notarized release from all persons, governmental entities, or political

20    subdivisions whose interests were sought to be protected by the protected classification or from

21    their legal representatives dated no more than 90 days prior to the date the request is made; or

22        (c)  any person to whom the record must be provided pursuant to a court order as provided

23    in Subsection (7) or a legislative subpoena as provided in Title 36, Chapter 14.

24        (5)  A governmental entity may disclose a private, controlled, or protected record to another

25    governmental entity, political subdivision, another state, the United States, or a foreign

26    government only as provided by Section 63-2-206.

27        (6)  Before releasing a private, controlled, or protected record, the governmental entity shall

28    obtain evidence of the requester's identity.

29        (7)  A governmental entity shall disclose a record pursuant to the terms of a court order

30    signed by a judge from a court of competent jurisdiction, provided that:

31        (a)  the record deals with a matter in controversy over which the court has jurisdiction;

- 16 -


1        (b)  the court has considered the merits of the request for access to the record; and

2        (c)  the court has considered and, where appropriate, limited the requester's use and further

3    disclosure of the record in order to protect privacy interests in the case of private or controlled

4    records, business confidentiality interests in the case of records protected under Subsections

5    63-2-304(1) and (2), and privacy interests or the public interest in the case of other protected

6    records;

7        (d)  to the extent the record is properly classified private, controlled, or protected, the

8    interests favoring access, considering limitations thereon, outweigh the interests favoring

9    restriction of access; and

10        (e)  where access is restricted by a rule, statute, or regulation referred to in Subsection

11    63-2-201(3)(b), the court has authority independent of this chapter to order disclosure.

12        (8) (a)  A governmental entity may disclose or authorize disclosure of private or controlled

13    records for research purposes if the governmental entity:

14        (i)  determines that the research purpose cannot reasonably be accomplished without use

15    or disclosure of the information to the researcher in individually identifiable form;

16        (ii)  determines that the proposed research is bona fide, and that the value of the research

17    outweighs the infringement upon personal privacy;

18        (iii)  requires the researcher to assure the integrity, confidentiality, and security of the

19    records and requires the removal or destruction of the individual identifiers associated with the

20    records as soon as the purpose of the research project has been accomplished;

21        (iv)  prohibits the researcher from disclosing the record in individually identifiable form,

22    except as provided in Subsection (8)(b), or from using the record for purposes other than the

23    research approved by the governmental entity; [and]

24        (v)  secures from the researcher a written statement of his understanding of and agreement

25    to the conditions of this subsection and his understanding that violation of the terms of this

26    subsection may subject him to criminal prosecution under Section 63-2-801[.]; and

27        (vi)  requires that the researcher complies with the provisions of Title 26, Chapter 40,

28    Genetic Testing Privacy Act, if the research involves genetic information.

29        (b)  A researcher may disclose a record in individually identifiable form if the record is

30    disclosed for the purpose of auditing or evaluating the research program and no subsequent use

31    or disclosure of the record in individually identifiable form will be made by the auditor or

- 17 -


1    evaluator except as provided by this section.

2        (c)  A governmental entity may require indemnification as a condition of permitting

3    research under this subsection.

4        (9) (a)  Under Subsections 63-2-201(5)(b) and 63-2-401(6) a governmental entity may

5    disclose records that are private under Section 63-2-302, or protected under Section 63-2-304 to

6    persons other than those specified in this section.

7        (b)  Under Subsection 63-2-403(11)(b) the Records Committee may require the disclosure

8    of records that are private under Section 63-2-302, controlled under Section 63-2-303, or protected

9    under Section 63-2-304 to persons other than those specified in this section.

10        (c)  Under Subsection 63-2-404(8) the court may require the disclosure of records that are

11    private under Section 63-2-302, controlled under Section 63-2-303, or protected under Section

12    63-2-304 to persons other than those specified in this section. 

13        Section 22.  Section  63-2-302 is amended to read:

14         63-2-302.  Private records.

15        (1)  The following records are private:

16        (a)  records concerning an individual's eligibility for unemployment insurance benefits,

17    social services, welfare benefits, or the determination of benefit levels;

18        (b)  records containing data on individuals describing medical history, diagnosis, condition,

19    treatment, evaluation, genetic information, or similar medical data;

20        (c)  records of publicly funded libraries that when examined alone or with other records

21    identify a patron;

22        (d)  records received or generated for a Senate or House Ethics Committee concerning any

23    alleged violation of the rules on legislative ethics, prior to the meeting, and after the meeting, if

24    the ethics committee meeting was closed to the public;

25        (e)  records received or generated for a Senate confirmation committee concerning

26    character, professional competence, or physical or mental health of an individual:

27        (i)  if prior to the meeting, the chair of the committee determines release of the records:

28        (A)  reasonably could be expected to interfere with the investigation undertaken by the

29    committee; or

30        (B)  would create a danger of depriving a person of a right to a fair proceeding or impartial

31    hearing;

- 18 -


1        (ii)  after the meeting, if the meeting was closed to the public;

2        (f)  records concerning a current or former employee of, or applicant for employment with,

3    a governmental entity that would disclose that individual's home address, home telephone number,

4    social security number, insurance coverage, marital status, or payroll deductions; and

5        (g)  that part of a record indicating a person's social security number if provided under

6    Section 31A-23-202, 31A-26-202, 58-1-301, 61-1-4, or 61-2-6.

7        (2)  The following records are private if properly classified by a governmental entity:

8        (a)  records concerning a current or former employee of, or applicant for employment with

9    a governmental entity, including performance evaluations and personal status information such as

10    race, religion, or disabilities, but not including records that are public under Subsection

11    63-2-301(1)(b) or 63-2-301(2)(o), or private under Subsection 63-2-302(1)(b);

12        (b)  records describing an individual's finances, except that the following are public:

13        (i)  records described in Subsection 63-2-301(1);

14        (ii)  information provided to the governmental entity for the purpose of complying with a

15    financial assurance requirement; or

16        (iii)  records that must be disclosed in accordance with another statute;

17        (c)  records of independent state agencies if the disclosure of those records would conflict

18    with the fiduciary obligations of the agency;

19        (d)  other records containing data on individuals the disclosure of which constitutes a

20    clearly unwarranted invasion of personal privacy; and

21        (e)  records provided by the United States or by a government entity outside the state that

22    are given with the requirement that the records be managed as private records, if the providing

23    entity states in writing that the record would not be subject to public disclosure if retained by it.

24        Section 23.   Effective date.

25        This act takes effect on July 1, 1998.


- 19 -




 Legislative Review Note
    as of   1-16-98  4:47 PM


A limited legal review of this bill raises no obvious constitutional or statutory concerns.

 Office of Legislative Research and General Counsel


- 20 -
[Bill Documents][Bills Directory]









Who represents me?





Remember my Legislators





State Senate
		350 North State, Suite 320
		PO Box 145115
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1035
		Fax: (801) 326-1475



House of Representatives
		350 North State, Suite 350
		PO Box 145030
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1029
		Fax: (801) 326-1544










Home
Mobile Site
Site Map
Calendar
Code / Constitution
House
Senate

Terms of Use/Privacy Policy

ADA
Utah.gov







